Zasloff Michael A
- SEC CIK
- 0001033511
No open-market purchases or sales filed in the past year.
Current role at each company
- AMPH Amphastar Pharmaceuticals, Inc.Directoras of Jun 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Zasloff Michael A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 (view filing) | Mar 5 | 1 day | Zasloff Michael ADirector | SSale | −12.5K | $47.18 | −$589.7K | −37.0%21.3K after | 2 lots |
| Aug 16, 2023 (view filing) | Aug 15 | 1 day | Zasloff Michael ADirector | SSale | −12.8K | $57.22 | −$730.1K | −27.4%33.8K after | |
| May 16, 2023 (view filing) | May 15 | 1 day | Zasloff Michael ADirector | SSale | −7.50K | $42.18 | −$316.4K | −14.6%43.9K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Zasloff Michael ADirector | SSale | −10.3K | $35.61 | −$366.5K | −17.9%47.2K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Zasloff Michael ADirector | SSale | −10.0K | $33.71 | −$337.1K | −17.5%47.2K after |